Category Liver Cancer


AACR: New Biomarker to Identify Hepatitis B-Infected Patients at Risk for Liver Cancer

CHICAGO— Hepatitis B-infected patients with significantly longer telomeres—the caps on the end of chromosomes that protect our genetic data— were found to have an increased risk of getting liver cancer compared to those with shorter ones, according to findings presented by researchers at Jefferson’s Kimmel Cancer Center at the American Association for Cancer Research (AACR) …


Kimmel Cancer Center at Jefferson Celebrates 20 Years of Patient Care and Cancer Discovery

From October forward, the Kimmel Cancer Center at Jefferson (KCC), a National Cancer Institute-designated cancer center, is celebrating 20 years of service to the community and the groundbreaking cancer research from the scientists and physicians who’ve provided an invaluable contribution to medical science and healthcare. “This is truly a milestone for the Kimmel Cancer Center—it’s …


Dr. Greenbaum to co-organize International Conference on Liver Biology

Dr. Linda Greenbaum will co-organize, (along with Dr. Jessica Zucman-Rossi (Professor of Medicine (Oncology), University of Paris Descartes), the 2012 FASEB Summer Research Conference  on “Liver Biology: Fundamental Mechanisms & Translational Applications.  The conference will take place in Snowmass, Colorado July 29-August 3, 2012 and will bring together 150- 200 outstanding basic and translational scientists dedicated …


Dr. Greenbaum selected as Chair of AASLD/ALF Joint Grant Review Committee

Dr. Linda Greenbaum was selected as the  Chair of the  American Association for the Study of Liver Diseases (AASLD)/ American Liver Foundation (ALF) joint grant review committee for the term 2011-14.


New Tumor Tracking Technique for Radiotherapy Spares Healthy Tissue, Could Improve Cancer Treatment

Medical physicists at Thomas Jefferson University and Jefferson’s Kimmel Cancer Center have demonstrated a new real-time tumor tracking technique that can help minimize the amount of radiation delivered to surrounding healthy tissue in a patient—up to 50 percent less in some cases—and maximize the dose the tumor receives. Respiratory and cardiac motions have been found …


Vitamin K and Sorafenib Combination Demonstrated Anti-Tumor Effects in Pancreas Cancer and Hepatocellular Carcinoma

A combination of Sorafenib and Vitamin K had an effect in vitro on both human pancreas cancer and hepatocellular carcinoma, according to researchers from the Kimmel Cancer Center at Jefferson. Data from the two studies were presented at the AACR 100th Annual Meeting 2009 in Denver. (Abstract #5470 and #5483) Vitamin K1 or Vitamin K2, …


New Jefferson Trial to Test Radiation-Emitting Beads Against Advanced Liver Cancer

Liver cancer specialists at Jefferson’s Kimmel Cancer Center in Philadelphia are beginning an 18-month study of a new treatment for liver cancer. The therapy entails injecting tiny beads that emit small amounts of radiation into the liver’s main artery while also blocking the blood supply feeding the cancer’s growth. The technique, called radioembolization, has been …